文献速递糖尿病

血浆Afamin浓度与现患及新发2型糖尿病相关:超过20,000人的汇总分析

Plasma Concentrations of Afamin Are Associated With Prevalent and Incident Type 2 Diabetes: A Pooled Analysis in More Than 20,000 Individuals.
PubMed 文献 · Diabetes Care · 2017-09-06

该汇总分析纳入8项前瞻性队列研究的基线(n=20,136)和随访(n=14,017)个体数据,采用随机效应Meta分析。Afamin每升高10 mg/L与现患2型糖尿病(OR 1.19,95%CI 1.12-1.26)、HOMA-IR(β 0.110,95%CI 0.089-0.132)及新发2型糖尿病(OR 1.30,95%CI 1.23-1.38)独立相关,并改善风险分类准确性。

要点

  • Afamin每升高10 mg/L与现患2型糖尿病独立相关(OR 1.19,95%CI 1.12-1.26)。
  • 基线Afamin是新发2型糖尿病的独立预测因子(OR 1.30,95%CI 1.23-1.38)。
  • Afamin加入扩展校正模型后显著改善风险分类准确性。

核心结论

  • 该汇总分析在超过20,000人中显示Afamin与胰岛素抵抗、2型糖尿病患病率和发病率强烈相关,且独立于主要代谢危险因素或参数。
  • Afamin可能是识别2型糖尿病高风险个体的有前景的新标志物。

研究设计与样本

  • 研究纳入8项前瞻性队列研究的个体水平基线数据(n=20,136)和随访数据(n=14,017)。
  • 研究水平数据采用随机效应Meta分析合并。
  • 主要结局为现患和新发2型糖尿病、糖尿病前期及胰岛素抵抗,并分析新发2型糖尿病的判别与重分类。

主要发现

  • 各研究平均Afamin浓度为61至73 mg/L。
  • 8项研究共包含1,398例现患2型糖尿病和585例新发2型糖尿病。
  • Afamin每升高10 mg/L与现患2型糖尿病相关(OR 1.19,95%CI 1.12-1.26,P=5.96×10^-8)。
  • Afamin与HOMA-IR评估的胰岛素抵抗正相关(β 0.110,95%CI 0.089-0.132,P=1.37×10^-23)。
  • 基线Afamin是新发2型糖尿病的独立预测因子(OR 1.30,95%CI 1.23-1.38,P=3.53×10^-19),加入扩展校正模型后显著改善风险分类准确性。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The human vitamin E-binding glycoprotein afamin is primarily expressed in the liver and has been associated with prevalent and incident metabolic syndrome. These data were in line with observations in transgenic mice. We thus investigated whether afamin concentrations are associated with prediabetes, type 2 diabetes, and insulin resistance (IR). RESEARCH DESIGN AND METHODS: Individual-level baseline (n = 20,136) and follow-up data (n = 14,017) of eight prospective cohort studies were investigated. Study-level data were combined using random-effects meta-analyses. Main outcomes were prevalent and incident type 2 diabetes, prediabetes, and IR. Discrimination and reclassification of participants was analyzed for incident type 2 diabetes. RESULTS: Mean afamin concentrations between studies ranged from 61 to 73 mg/L. The eight studies included 1,398 prevalent and 585 incident cases of type 2 diabetes. Each increase of afamin by 10 mg/L was associated with prevalent type 2 diabetes (odds ratio [OR] 1.19 [95% CI 1.12-1.26], P = 5.96 × 10-8). Afamin was positively associated with IR assessed by HOMA-IR (β 0.110 [95% CI 0.089-0.132], P = 1.37 × 10-23). Most importantly, afamin measured at baseline was an independent predictor for 585 incident cases of type 2 diabetes (OR 1.30 [95% CI 1.23-1.38], P = 3.53 × 10-19) and showed a significant and valuable gain in risk classification accuracy when added to this extended adjustment model. CONCLUSIONS: This pooled analysis in >20,000 individuals showed that afamin is strongly associated with IR, prevalence, and incidence of type 2 diabetes independent of major metabolic risk factors or parameters. Afamin might be a promising novel marker for the identification of individuals at high risk for the development of type 2 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Kollerits B, Lamina C, Huth C, et al. Plasma Concentrations of Afamin Are Associated With Prevalent and Incident Type 2 Diabetes: A Pooled Analysis in More Than 20,000 Individuals. Diabetes Care. 2017. PMID: 28877915. doi:10.2337/dc17-0201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。